Gerstein HC, Li Z, Ramasundarahettige C, Baek S, et al. Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial. Circulation 2023 Feb 20. doi: 10.1161/CIRCULATIONAHA.122.063716.
PMID: 36802715